Bioimaging analysis of nuclear factor‐κB activity in Philadelphia chromosome‐positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor‐α‐stimulated changes to the microenvironment

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Science

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2011.02039.xPMID 21777350PMCID PMC11158770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour necrosis factor and cancer

  2009cited by this paper
• Inactivation of NF-kappaB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues.

  2008cited by this paper
• Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene

  2008cited by this paper
• Activation‐induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma

  2008cited by this paper
• Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

  2008cited by this paper
• Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

  2008cited by this paper
• Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells

  2007cited by this paper
• Targeting NF-jB in hematologic malignancies

  2006cited by this paper
• In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Targeting NF-κB in hematologic malignancies

  2006cited by this paper
• Development of a Unique In Vitro and In Vivo Model System of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-ALL) with Emphasis on Cell to Cell Interaction.

  2006cited by this paper
• Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• Targeting NF-kappaB in hematologic malignancies.

  2006cited by this paper
• Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

  2006cited by this paper
• Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.

  2005cited by this paper
• Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition

  2005cited by this paper
• B cells.

  2005cited by this paper
• The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation.

  2005cited by this paper
• Constitutive NF-κB/Rel Activation in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

  2004cited by this paper
• NF-κB functions as a tumour promoter in inflammation-associated cancer

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).

  2004cited by this paper
• A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells

  2004cited by this paper
• Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector

  2003cited by this paper
• BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.

  2002cited by this paper
• Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

  2002cited by this paper
• Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation.

  2002cited by this paper
• Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

  2002cited by this paper
• Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells

  2000cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation.

  1998cited by this paper
• A requirement for NF-κB activation in Bcr–Abl-mediated transformation

  1998cited by this paper
• Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).

  1997cited by this paper
• Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

  1997cited by this paper
• Activation of p65 NF-κB protein by p210BCR – ABL in a myeloid cell line (P210BCR – ABL activates p65 NF-κB)

  1997cited by this paper
• Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique.

  1996cited by this paper
• Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

  1996cited by this paper
• TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

  1996cited by this paper
• Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.

  1996cited by this paper
• Suppression of TNF-α-Induced Apoptosis by NF-κB

  1996cited by this paper
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

  1996cited by this paper
• R~~/NF-KB /IKB familv: intimate tales of association and dissociation

  1995cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper
• Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).

  1992cited by this paper
• Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation

  1991cited by this paper
• In situ detection of tumour necrosis factor in human ovarian cancer specimens.

  1990cited by this paper
• A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

  1987cited by this paper
• Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

  1987cited by this paper

• Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias

  2023cites this paper
• Serum Tumor Necrosis Factor-Alpha Levels in Acute Leukemia and Its Prognostic Significance

  2022cites this paper
• THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia

  2020cites this paper
• Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach

  2020cites this paper
• The impact of inflammation and cytokine expression of PM2.5 in AML.

  2018cites this paper
• The bone marrow microenvironment in health and disease at a glance

  2018cites this paper
• The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators.

  2018cites this paper
• Tumor necrosis factor α in the onset and progression of leukemia.

  2017cites this paper
• TNF-alpha in onset and progression of leukemia

  2016cites this paper
• Combined Delivery and Anti-Cancer Activity of Paclitaxel and Curcumin Using Polymeric Micelles.

  2015cites this paper
• Establishment of a bioluminescent imaging-based in vivo leukemia model by intra-bone marrow injection.

  2012cites this paper
• Chapter five--The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities.

  2012cites this paper
• Pharmacogenomic considerations of xenograft mouse models of acute leukemia.

  2012cites this paper